NVUS - Novus Therapeutics Inc. (NVUS) CEO David-Alexandre Gros on Q3 2020 Results - Earnings Call Transcript
Novus Therapeutics, Inc. (NVUS) Q3 2020 Earnings Conference Call November 16, 2020 04:30 PM ET Company Participants Jon Kuwahara - Senior Vice President of Finance David-Alexandre Gros - Chief Executive Officer Steve Perrin - President & Chief Scientific Officer Conference Call Participants Presentation Operator Good day and welcome to the Novus Therapeutics Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] And as a reminder, this conference is being recorded. I'd now like to turn the call over to Jon Kuwahara, Senior Vice President of Finance. Please, go ahead. Jon Kuwahara Good afternoon and thank you all for joining Novus Therapeutics Fiscal 2020 Third Quarter Financial Results Conference Call. With me today are two members of our leadership team: David-Alexandre Gros, Chief Executive Officer; and Steve Perrin, President and Chief Scientific Officer.
For further details see:
Novus Therapeutics, Inc. (NVUS) CEO David-Alexandre Gros on Q3 2020 Results - Earnings Call Transcript